Jennifer M. Golas

Statistics

Publications

Citations

1.1K

H-Index

Active since

2003

Affiliations

Pearl River Community College(Current)

Ziopharm Oncology (United States)

Pfizer (United States)

Women's Health Research Institute

Jennifer M. Golas is an author at Pearl River Community College specializing in src family kinase inhibitors, tyrosine kinase inhibitors, and medicinal chemistry.

Publications per year

2003–2011

Publications

SKI-606, a 4-anilino-3-quinolinecarbonitrile dual inhibitor of Src and Abl kinases, is a potent antiproliferative agent against chronic myelogenous leukemia cells in culture and causes regression of K562 xenografts in nude mice.

Jennifer M. Golas, Kim Arndt, Carlo Etienne et al. · PubMed · 2003 · 414 citations

Medicine, Oncology, Pharmacology +17

SKI-606, a Src/Abl Inhibitor with<i>In vivo</i>Activity in Colon Tumor Xenograft Models

Jennifer M. Golas, Judy Lucas, Carlo Etienne et al. · Cancer Research · 2005 · 134 citations · Full text

Medicine, Oncology, Pharmacology +17

Discovery of Benzisoxazoles as Potent Inhibitors of Chaperone Heat Shock Protein 90

Ariamala Gopalsamy, Mengxiao Shi, Jennifer M. Golas et al. · Journal of Medicinal Chemistry · 2008 · 95 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10

7-Alkoxy-4-phenylamino-3-quinolinecar-bonitriles as Dual Inhibitors of Src and Abl Kinases

Diane H. Boschelli, Yanong D. Wang, S.A. Johnson et al. · Journal of Medicinal Chemistry · 2004 · 73 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Synthesis and Src Kinase Inhibitory Activity of 2-Phenyl- and 2-Thienyl-7-phenylaminothieno[3,2-<i>b</i>]pyridine-6-carbonitriles

Diane H. Boschelli, Biqi Wu, Ana Carolina Barrios Sosa et al. · Journal of Medicinal Chemistry · 2005 · 46 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

1–5 of 21